Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05537311 · ClinicalTrials.gov registry record · NA

Reducing Isolation and Feeling of Loneliness During Critical Illness

A NA study, sponsored by Kirby Mayer.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT05537311: Completed NA study, sponsored by Kirby Mayer.

NCT05537311 is a NA study that has completed, run by Kirby Mayer. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05537311, a NA study, has completed, sponsored by Kirby Mayer.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The trial is a pilot-randomized trial testing feasibility and limited-efficacy of delivering social engagement using technologic strategies to reduce periods of social isolation.

Primary Outcome

Determine the number of sessions delivered per number of sessions scheduled. The study sample size of 12 subjects to receive the intervention, and each subject in the intervention should receive 5 sessions each = 60 sessions total; success will be considered 75% of sessions delivered (45 sessions completed of 60 planned).

Interventions

  • BEHAVIORAL Social Engagement

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2022-07-27
Est. Completion 2023-07-01
Phase NA
Kirby Mayer

4 total trials

What the finished NCT05537311 record still lists

NCT05537311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Social Engagement is the first listed.

NCT05537311 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05537311 about?

NCT05537311 is a clinical study titled "Reducing Isolation and Feeling of Loneliness During Critical Illness". The trial is a pilot-randomized trial testing feasibility and limited-efficacy of delivering social engagement using technologic strategies to reduce periods of social isolation.

What is the current status of trial NCT05537311?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-07-27. Estimated completion is 2023-07-01.

What interventions are being tested in trial NCT05537311?

The interventions under investigation include: Social Engagement (BEHAVIORAL).

Who is sponsoring clinical trial NCT05537311?

This trial is sponsored by Kirby Mayer, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05537311's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05537311, the US trial registry maintained by the National Library of Medicine. NCT05537311 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.